Pg 47 | Cover Story

SMART Practices for Responding to FDA Observational Warnings Using Generative AI

Pg 47 | Cover Story

SMART Practices for Responding to FDA Observational Warnings Using Generative AI

Navigating the Digital Frontier

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
Get a glimpse

Section Overview

News Around the World

Pharma Now

Roche’s PATHWAY HER2 Test Gains FDA Approval For HER2-Ultralow Breast Cancer

Roche’s PATHWAY HER2 test now identifies HER2-ultralow breast cancer patients eligible for ENHERTU treatment.

MAGAZINE ARTICLE by

Pharma Now

Telix Receives European Approval for Prostate Cancer Imaging Agent

Illuccix secures European marketing approval, advancing prostate cancer imaging standards.

MAGAZINE ARTICLE by

Pharma Now

Merck's WELIREG® Gains Priority FDA Review for Rare Tumors

FDA accepts Merck's sNDA for WELIREG to treat advanced PPGL, with a target decision by May 26, 2025.

MAGAZINE ARTICLE by

Pharma Now

PM Modi Addresses Completion Of Indian Genome Project, Boosting Healthcare And Precision

PM Modi hails Genome India Project for revolutionizing India's healthcare and genetic research.

MAGAZINE ARTICLE by

News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news